NCM
ACHV icon

Next Capital Management’s Achieve Life Sciences ACHV Stock Holding History

Next Capital Management’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$103K Buy
34,995
+18,865
+117% +$83.8K 0.03% 130
2025
Q4 		$80.2K Hold
16,130
– – 0.03% 132
2025
Q3 		$50.8K Buy
+16,130
New +$44.3K 0.02% 133

Other funds holding ACHV

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Next Capital Management's ACHV Position: Q1 2026 in Review

Next Capital Management increased its Achieve Life Sciences (ACHV) stake by 117% in Q1 2026, buying an estimated $83.8K and bringing the position to 34,995 shares worth $103K. The position accounts for 0.03% of the portfolio, ranked #130.

Next Capital Management first reported a position in ACHV in Q3 2025 and has held it in 3 quarters since. 81 funds tracked by Wall St. Rank hold ACHV as of Q1 2026.

  • Next Capital Management held 34,995 shares of Achieve Life Sciences worth $103K as of Q1 2026.
  • Next Capital Management bought 18,865 Achieve Life Sciences shares in Q1 2026, an estimated $83.8K.
  • Achieve Life Sciences made up 0.03% of Next Capital Management's portfolio in Q1 2026, its #130 holding.
  • Next Capital Management first reported a position in Achieve Life Sciences in Q3 2025 and has held it in 3 quarters since.
  • 81 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q1 2026.

Based on Next Capital Management's 13F filing for Q1 2026, filed 7 May 2026.